In this episode, Justin talks with Paul Rennie, CEO of late-stage drug development company Paradigm Biopharmaceutics (ASX:PAR).
Learn more about your ad choices. Visit megaphone.fm/adchoices
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
This website doesn't track the visitors or use any cookies. Made by Alex Barredo. Send your feedback to alex@barredo.es.
